What is the Elanco Animal Health Incorporated stock price forecast?

Elanco Animal Health Incorporated is currently trading at $24.23. View real-time AI analysis on Alpha Lenz.

What is Elanco Animal Health Incorporated insider trading activity?

View the latest insider trading data for Elanco Animal Health Incorporated on Alpha Lenz.

What is Elanco Animal Health Incorporated's P/E ratio?

Elanco Animal Health Incorporated's P/E ratio is -51.8.

Elanco Animal Health Incorporated

NYSE · ELAN

$24.23-0.06(-0.25%)Pre-market

Ask about Elanco Animal Health Incorporated's future dividend policy...

Alpha Chat Insight

“Elanco Animal Health Incorporated trades at a P/E of -51.8 (undervalued) with modest ROE of -3.7%.”

Ask for details →

Company Overview

Elanco Animal Health Incorporated is a leading global pharmaceutical company specializing in animal health. Its primary function is the development and delivery of innovative products and solutions to prevent and treat diseases in both companion animals and livestock, including dogs, cats, cattle, poultry, swine, sheep, and aquaculture species. With a heritage dating to 1954, Elanco combines six decades of research-driven expertise and operates across more than 90 countries, earning over half its revenue from international markets. The company serves veterinarians, farmers, and pet owners through a diverse portfolio that addresses significant animal health challenges, improving animal welfare while indirectly supporting food security and public health. Elanco’s ongoing commitment to research and sustainable practices positions it as a critical partner in enhancing animal well-being, supporting the agricultural sector, and advancing the global animal health industry.

CEOMr. Jeffrey N. Simmons

Websitehttps://www.elanco.com

SectorHealthcare

IndustryDrug Manufacturers - Specialty & Generic

Employees9,000

Company Statistics

FY 2025

Profile

$12.03BMarket Cap

$4.71BRevenue

0.00Shares Out

9,000Employees

Margins

54.99%Gross

19.36%EBITDA

5.34%Operating

-4.75%Pre-Tax

-4.92%Net

Valuation

-51.84P/E

1.84P/B

2.55EV/Sales

16.98EV/EBITDA

42.35P/FCF

Growth (CAGR)

2.25%Rev 3Yr

7.59%Rev 5Yr

-13.10%Op Inc 3Yr

N/AOp Inc 5Yr

N/ANet Inc 3Yr

N/ANet Inc 5Yr

Returns

-1.79%ROA

-3.67%ROE

-0.03%ROIC

Financial Health

$545.00MCash & Cash Equivalents

$6.27BNet Debt

104.03%Debt/Equity

N/AInterest Cov

Alpha Chat Insight

“Elanco Animal Health Incorporated trades at a P/E of -51.8 (undervalued) with modest ROE of -3.7%.”

Ask for details →

Frequently Asked Questions

Elanco Animal Health Incorporated (ticker: ELAN) is a company listed on NYSE in the Healthcare sector (Drug Manufacturers - Specialty & Generic). It has approximately 9,000 employees. Market cap is $12.0B.

The current price is $24.23 with a P/E ratio of -51.84x and P/B of 1.84x.

ROE is -3.67% and operating margin is 5.34%. Annual revenue is $4.7B.